The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $114.19

Today's change+0.95 +0.84%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $114.19

Today's change+0.95 +0.84%
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.

Core Laboratories NV up (U.S.)$0.95

Core Laboratories NV closed up Friday by (U.S.)$0.95 or 0.84% to (U.S.)$114.19. Although unchanged over the last five days, shares are down 4.87% for the last year to date. This security has underperformed the S&P 500 by 11.41% during the last year.

Key company metrics

  • Open(U.S.) $112.69
  • Previous close(U.S.) $113.24
  • High(U.S.) $114.27
  • Low(U.S.) $111.91
  • Bid / Ask-- / --
  • YTD % change-4.87%
  • Volume496,423
  • Average volume (10-day)354,374
  • Average volume (1-month)389,465
  • Average volume (3-month)453,751
  • 52-week range(U.S.) $96.30 to (U.S.) $135.49
  • Beta1.45
  • Trailing P/E77.99×
  • P/E 1 year forward54.81×
  • Forward PEG2.74×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield1.93%
  • Trailing EPS(U.S.) $1.46
Updated February 24 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX1.57%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue150143148154
Total other revenue--------
Total revenue150143148154
Gross profit37363841
Total cost of revenue113107110113
Total operating expense128122128131
Selling / general / administrative981111
Research & development--------
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total0000
Operating income22212023
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax19191720
Income after tax15171715
Income tax, total4214
Net income15171715
Total adjustments to net income--------
Net income before extra. items15171715
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items15171715
Inc. avail. to common incl. extra. items15171715
Diluted net income15171715
Dilution adjustment--------
Diluted weighted average shares44444442
Diluted EPS excluding extraordinary itemsvalue per share0.350.380.380.36
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.350.380.380.35